Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Enzo Biochem's share price for the quarter that ended in Jan. 2024 was $1.26. Enzo Biochem's Shares Outstanding (EOP) for the quarter that ended in Jan. 2024 was 50.49 Mil. Therefore, Enzo Biochem's market cap for the quarter that ended in Jan. 2024 was $63.62 Mil.
Enzo Biochem's quarterly market cap
declined
from Jul. 2023 ($74.00 Mil) to Oct. 2023 ($67.66 Mil) and
declined
from Oct. 2023 ($67.66 Mil) to Jan. 2024 ($63.62 Mil).
Enzo Biochem's annual market cap
declined
from Jul. 2021 ($158.02 Mil) to Jul. 2022 ($115.47 Mil) and
declined
from Jul. 2022 ($115.47 Mil) to Jul. 2023 ($74.00 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Enzo Biochem's Enterprise Value for Today is $0.73 Mil.
Enzo Biochem Market Cap Historical Data
The historical data trend for Enzo Biochem's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Enzo Biochem's Market Cap
For the Diagnostics & Research subindustry, Enzo Biochem's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enzo Biochem's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Market Cap distribution charts can be found below:
* The bar in red indicates where Enzo Biochem's Market Cap falls into.
Enzo Biochem Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Enzo Biochem's Market Cap for the fiscal year that ended in Jul. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enzo Biochem (NYSE:ENZ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Enzo Biochem Market Cap Related Terms
Thank you for viewing the detailed overview of Enzo Biochem's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENZ has been successfully added to your 